Drawing for MDS PROTEOMICS

USPTO serial 78066165

MDS PROTEOMICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SNYDER, NELSON B
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MDS PROTEOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donna M. Weinstein

Charles E. Weinstein, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport World Trade Center WestBoston, MA 02210

Goods and services

ClassDescriptionStatusFirst use
009Computer programs relating to assays for the diagnosis of diseases, namely computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substancesACTIVE—
042Medical research, namely developing assays for the diagnosis of diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 18, 2008MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 18, 2008ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 18, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 25, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 5, 2007NPUBNOTICE OF PUBLICATION—
Aug 23, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 20, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Aug 20, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 20, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 20, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
May 8, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 22, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2007RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 3, 2007ALIEASSIGNED TO LIE—
Jun 8, 2006RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 8, 2005RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 8, 2005RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 8, 2004RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 14, 2003CFITCASE FILE IN TICRS—
Jul 18, 2003DOCKASSIGNED TO EXAMINER—
Feb 27, 2003DOCKASSIGNED TO EXAMINER—
Jun 17, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 10, 2002CNSLLETTER OF SUSPENSION MAILED—
Feb 15, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 17, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance